See what clients say about Ropack

Ropack Inc. Acquires Pharmaceutical Facilities in Long Island, NY

PRESS RELEASE
For Immediate Release
December 8, 2015

Ropack Inc. Acquires Pharmaceutical Facilities in Long Island, NY
Expands Capabilities and Establishes US Presence

Montreal, Canada – December 8, 2015 – Ropack Inc., provider of contract manufacturing and packaging services for the pharmaceutical and nutraceutical industries, announced the purchase of two pharmaceutical facilities in Long Island, New York. The acquisition significantly expands the company’s capabilities which will now include research and development, formulation, lab analysis and commercial and clinical manufacturing, complementing its well-established solid oral dosage packaging and clinical study distribution.

The buildings, formerly operated by Forest Laboratories, LLC, total 213,700 square feet and are a realization of Ropack Inc.’s strategic expansion plan. “It has been a longstanding goal to broaden our service offerings,” noted Yves Massicotte, President and CEO. “To establish a presence in the United States at the same time makes this acquisition ideal.” Activities in the US territory will be managed through Ropack USA Inc. Mr. Massicotte added that Ropack Inc. and Ropack USA Inc. will now be known as “Ropack Pharma Solutions.”

“The purchase of these two state-of-the-art pharmaceutical facilities on Long Island will enable Ropack Pharma Solutions to provide its current and future customers with comprehensive solid oral dosage development, manufacturing and packaging solutions,” remarked Paul Dupont, Vice President of Marketing and Business Development. “This acquisition will add considerable capacity and key technologies to support projects from formulation development through commercialization.”

Ropack Inc., celebrating its 40th anniversary in 2016, operates four facilities in Montreal, Canada, for the packaging of solid oral dosage in bottles, flip-top vials, blister packs, stick-packs and sachets. It also is a leading Canadian clinical trial depot. It counts among its current customers many of the largest and most-respected companies in the pharmaceutical and nutraceutical industries.

###

Ropack Pharma Solutions (RPS) supports solid oral dosage projects from early-stage formulation through clinical manufacturing, packaging, distribution and commercial manufacturing and packaging. Facilities in Montreal, Canada, and Long Island, New York, are cGMP-compliant, site-licensed by the FDA and Health Canada-certified.

Like what you read? Share with your network:

 

 
< Previous Press Release . . . Next Press Release > 

paul dupont

 

PAUL DUPONT
VP, Marketing and Business Development
Email Paul Dupont